InvestorsHub Logo
Followers 53
Posts 11271
Boards Moderated 9
Alias Born 06/25/2009

Re: None

Monday, 12/31/2018 10:42:37 AM

Monday, December 31, 2018 10:42:37 AM

Post# of 182
ITEM 7.01. REGULATION FD 8K

As previously disclosed in the Prospectus filed with the Securities and Exchange Commission on October 12, 2018, in connection with its initial public offering, Livent Corporation (the "Company") had granted the underwriters an option to purchase up to an aggregate of 3,000,000 additional shares of common stock to cover over-allotments at the initial public offering price, less the underwriting discount, for 30 days after the date of the Prospectus. On November 8, 2018, the underwriters exercised in full their option to purchase an additional 3,000,000 shares.

The Company sold an aggregate of 23,000,000 shares of its common stock with net proceeds to the Company of approximately $368 million, after deducting underwriting discounts and commissions and estimated offering expenses. As of November 13, 2018, the Company had 146,000,000 shares of its common stock outstanding. The closing of the sale of 20,000,000 shares was completed on October 15, 2018 and the closing of the sale of 3,000,000 shares pursuant to the full exercise by the underwriters of their option to purchase additional shares was completed on November 13, 2018. The net proceeds from the sales of the shares in the public offering, including the option shares, are to be distributed to the Company’s parent, FMC Corporation.

https://ih.advfn.com/stock-market/NYSE/livent-corp-LTHM/stock-news/78681375/current-report-filing-8-k

IMHO

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LTHM News